Trials / Completed
CompletedNCT00556270
Efficacy of Matrifen in Patients Older Than 18 Years With Severe, Chronic Pain
Matrifen for Therapy of Severe, Chronic Pain.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Nycomed · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the efficacy and safety of matrifen in patients with severe and chronic pain who can only be sufficiently treated with opioid analgesics (WHO class 3).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Matrifen | as defined in the Summary of Product Characteristics (Fachinformation Chapter 4.2) |
Timeline
- Start date
- 2007-11-01
- Completion
- 2008-05-01
- First posted
- 2007-11-09
- Last updated
- 2012-05-07
Locations
815 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00556270. Inclusion in this directory is not an endorsement.